» Articles » PMID: 33142944

Clinical Changes and Uterine Hemodynamic in Pyometra Medically Treated Bitches

Overview
Journal Animals (Basel)
Date 2020 Nov 4
PMID 33142944
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Cystic endometrial hyperplasia-pyometra complex is a canine endometrial disorder, considered the most common and important among uterine diseases. The treatment of choice is ovariohysterectomy, but medical treatments have become an alternative. However, no studies have been performed in order to evaluate uterine hemodynamic changes during medical treatment for pyometra bitches. Therefore, the aim of this study was to compare the effectiveness of two medical protocols by means of clinical (heart rate, respiratory rate and body temperature), medullar response (complete blood count (CBC)) and uterine hemodynamic evaluation in pyometra bitches. For such purpose, 10 bitches with pyometra were assigned to two groups: Aglepristone Group (n = 5) and Associative Group (aglepristone + prostaglandin; n = 5). The Associative Group had altered respiratory rate and decreased body temperature. The Aglepristone Group had decreased plasma protein, however, leukocyte count reduced over time for both therapeutic protocols. Uterine area and vascularization score decreased throughout treatment. There was a significant reduction in uterine perimeter, area and vascularization score. The Associative Group had lower final diastolic velocity and higher systole:diastole ratio (S/D), pulsatility index (PI) and resistance index (RI). In conclusion, both medical treatments are effective in reversing clinical and CBC changes of pyometra, especially aglepristone, however they cannot fully restore local uterine changes in a short-term evaluation. Conversely, associative therapy was more effective in decreasing uterine vascularization and modulating uterine blood flow.

Citing Articles

Drug Discovery in Canine Pyometra Disease Identified by Text Mining and Microarray Data Analysis.

Wang X, Yu G Biomed Res Int. 2023; 2023:7839568.

PMID: 37101686 PMC: 10125737. DOI: 10.1155/2023/7839568.


Antimicrobial use in the surgical treatment of canine pyometra: A questionnaire survey of Arizona-licensed veterinarians.

Lavin L, Maki L Vet Med Sci. 2023; 9(3):1124-1133.

PMID: 37051761 PMC: 10188056. DOI: 10.1002/vms3.1130.


Diagnostic and Therapeutic Advancements in the Field of Animal Reproduction.

Bazzano M, Troisi A Animals (Basel). 2022; 12(11).

PMID: 35681920 PMC: 9179508. DOI: 10.3390/ani12111457.


Prostaglandin and antigestagen in pyometra bitches: vascular and stereological effect.

da Rosa Filho R, Brito M, Faustino T, Almeida L, Correia Manoel V, Cogliati B Reprod Fertil. 2022; 2(2):95-105.

PMID: 35128446 PMC: 8812451. DOI: 10.1530/RAF-20-0020.

References
1.
Hagman R . Pyometra in Small Animals. Vet Clin North Am Small Anim Pract. 2018; 48(4):639-661. DOI: 10.1016/j.cvsm.2018.03.001. View

2.
Jurka P, Max A, Hawrynska K, Snochowski M . Age-related pregnancy results and further examination of bitches after aglepristone treatment of pyometra. Reprod Domest Anim. 2008; 45(3):525-9. DOI: 10.1111/j.1439-0531.2008.01288.x. View

3.
Jitpean S, Strom-Holst B, Emanuelson U, Hoglund O, Pettersson A, Alneryd-Bull C . Outcome of pyometra in female dogs and predictors of peritonitis and prolonged postoperative hospitalization in surgically treated cases. BMC Vet Res. 2014; 10:6. PMC: 3892096. DOI: 10.1186/1746-6148-10-6. View

4.
Novy M, Piasecki G, Jackson B . Effect of prostaglandins E2 and F-2-alpha on umbilical blood flow and fetal hemodynamics. Prostaglandins. 1974; 5(6):543-55. DOI: 10.1016/s0090-6980(74)80029-8. View

5.
Corrada Y, Arias D, Rodriguez R, Tortora M, Gobello C . Combination dopamine agonist and prostaglandin agonist treatment of cystic endometrial hyperplasia-pyometra complex in the bitch. Theriogenology. 2006; 66(6-7):1557-9. DOI: 10.1016/j.theriogenology.2006.01.004. View